Literature DB >> 26717111

Autodigestion: Proteolytic Degradation and Multiple Organ Failure in Shock.

Angelina E Altshuler1, Erik B Kistler, Geert W Schmid-Schönbein.   

Abstract

There is currently no effective treatment for multiorgan failure following shock other than supportive care. A better understanding of the pathogenesis of these sequelae to shock is required. The intestine plays a central role in multiorgan failure. It was previously suggested that bacteria and their toxins are responsible for the organ failure seen in circulatory shock, but clinical trials in septic patients have not confirmed this hypothesis. Instead, we review here evidence that the digestive enzymes, synthesized in the pancreas and discharged into the small intestine as requirement for normal digestion, may play a role in multiorgan failure. These powerful enzymes are nonspecific, highly concentrated, and fully activated in the lumen of the intestine. During normal digestion they are compartmentalized in the lumen of the intestine by the mucosal epithelial barrier. However, if this barrier becomes permeable, e.g. in an ischemic state, the digestive enzymes escape into the wall of the intestine. They digest tissues in the mucosa and generate small molecular weight cytotoxic fragments such as unbound free fatty acids. Digestive enzymes may also escape into the systemic circulation and activate other degrading proteases. These proteases have the ability to clip the ectodomain of surface receptors and compromise their function, for example cleaving the insulin receptor causing insulin resistance. The combination of digestive enzymes and cytotoxic fragments leaking into the central circulation causes cell and organ dysfunction, and ultimately may lead to complete organ failure and death. We summarize current evidence suggesting that enteral blockade of digestive enzymes inside the lumen of the intestine may serve to reduce acute cell and organ damage and improve survival in experimental shock.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26717111      PMCID: PMC4833612          DOI: 10.1097/SHK.0000000000000544

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  64 in total

1.  Apoptosis and differentiation in the crypt-villus unit of the rat small intestine.

Authors:  S Westcarr; P Farshori; J Wyche; W A Anderson
Journal:  J Submicrosc Cytol Pathol       Date:  1999-01

2.  Matrix metalloproteinase-9 in homocysteine-induced intestinal microvascular endothelial paracellular and transcellular permeability.

Authors:  Charu Munjal; Neetu Tyagi; David Lominadze; Suresh C Tyagi
Journal:  J Cell Biochem       Date:  2012-04       Impact factor: 4.429

3.  Successful treatment with continuous enteral protease inhibitor in a patient with severe septic shock.

Authors:  Y-T Lee; J Wei; Y-C Chuang; C-Y Chang; I-C Chen; C-F Weng; G W Schmid-Schönbein
Journal:  Transplant Proc       Date:  2012-04       Impact factor: 1.066

4.  Effects of hyperoxia on local and remote microcirculatory inflammatory response after splanchnic ischemia and reperfusion.

Authors:  Dan Waisman; Vera Brod; Rafael Wolff; Edmond Sabo; Mark Chernin; Zalman Weintraub; Avi Rotschild; Haim Bitterman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-04-24       Impact factor: 4.733

Review 5.  Enterokinase.

Authors:  N S Mann; S K Mann
Journal:  Proc Soc Exp Biol Med       Date:  1994-06

Review 6.  Stress-hyperglycemia, insulin and immunomodulation in sepsis.

Authors:  Paul E Marik; Murugan Raghavan
Journal:  Intensive Care Med       Date:  2004-02-26       Impact factor: 17.440

7.  Pancreatic digestive enzyme blockade in the small intestine prevents insulin resistance in hemorrhagic shock.

Authors:  Frank A DeLano; Geert W Schmid-Schönbein
Journal:  Shock       Date:  2014-01       Impact factor: 3.454

8.  The intestinal mucus layer is a critical component of the gut barrier that is damaged during acute pancreatitis.

Authors:  Jordan E Fishman; Gal Levy; Vamsi Alli; Xiaozhong Zheng; Damian J Mole; Edwin A Deitch
Journal:  Shock       Date:  2014-09       Impact factor: 3.454

9.  Protease activity increases in plasma, peritoneal fluid, and vital organs after hemorrhagic shock in rats.

Authors:  Angelina E Altshuler; Alexander H Penn; Jessica A Yang; Ga-Ram Kim; Geert W Schmid-Schönbein
Journal:  PLoS One       Date:  2012-03-27       Impact factor: 3.240

10.  Removal of luminal content protects the small intestine during hemorrhagic shock but is not sufficient to prevent lung injury.

Authors:  Angelina E Altshuler; Michael D Richter; Augusta E Modestino; Alexander H Penn; Michael J Heller; Geert W Schmid-Schönbein
Journal:  Physiol Rep       Date:  2013-10-20
View more
  10 in total

Review 1.  Mechanisms of I/R-Induced Endothelium-Dependent Vasodilator Dysfunction.

Authors:  Ronald J Korthuis
Journal:  Adv Pharmacol       Date:  2017-12-08

2.  Enteral tranexamic acid attenuates vasopressor resistance and changes in α1-adrenergic receptor expression in hemorrhagic shock.

Authors:  Marco Henry Santamaria; Federico Aletti; Joyce B Li; Aaron Tan; Monica Chang; Jessica Leon; Geert W Schmid-Schönbein; Erik B Kistler
Journal:  J Trauma Acute Care Surg       Date:  2017-08       Impact factor: 3.313

3.  What's New in Shock, May 2016?

Authors:  Monowar Aziz; Ping Wang
Journal:  Shock       Date:  2016-05       Impact factor: 3.454

4.  Mesenchymal stem cell extracellular vesicles mitigate vascular permeability and injury in the small intestine and lung in a mouse model of hemorrhagic shock and trauma.

Authors:  Mark Barry; Alpa Trivedi; Praneeti Pathipati; Byron Y Miyazawa; Lindsay R Vivona; Padma Priya Togarrati; Manisha Khakoo; Heather Tanner; Philip Norris; Shibani Pati
Journal:  J Trauma Acute Care Surg       Date:  2022-03-01       Impact factor: 3.697

5.  Intraluminal tranexamic acid inhibits intestinal sheddases and mitigates gut and lung injury and inflammation in a rodent model of hemorrhagic shock.

Authors:  Zhanglong Peng; Kechen Ban; Anthony LeBlanc; Rosemary A Kozar
Journal:  J Trauma Acute Care Surg       Date:  2016-08       Impact factor: 3.313

Review 6.  Complement in Pancreatic Disease-Perpetrator or Savior?

Authors:  Lucas Bettac; Stephanie Denk; Thomas Seufferlein; Markus Huber-Lang
Journal:  Front Immunol       Date:  2017-01-17       Impact factor: 7.561

7.  Digestive Enzyme Activity and Protein Degradation in Plasma of Heart Failure Patients.

Authors:  Vasiliki Courelli; Alla Ahmad; Majid Ghassemian; Chris Pruitt; Paul J Mills; Geert W Schmid-Schönbein
Journal:  Cell Mol Bioeng       Date:  2021-08-13       Impact factor: 2.321

Review 8.  The gut brain in a dish: Murine primary enteric nervous system cell cultures.

Authors:  Simone L Schonkeren; Tara T Küthe; Musa Idris; Ana C Bon-Frauches; Werend Boesmans; Veerle Melotte
Journal:  Neurogastroenterol Motil       Date:  2021-07-08       Impact factor: 3.960

9.  Effect of Montmorillonite powder on intestinal mucosal barrier in children with abdominal Henoch-Schonlein purpura: A randomized controlled study.

Authors:  Xiaolin Gao; Ruixue Miao; Yuhong Tao; Xiuying Chen; Chaomin Wan; Ruizhen Jia
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.889

Review 10.  The Gut-Lung Axis in Systemic Inflammation. Role of Mesenteric Lymph as a Conduit.

Authors:  Yonggang Ma; Xiaoyuan Yang; Victor Chatterjee; Mack H Wu; Sarah Y Yuan
Journal:  Am J Respir Cell Mol Biol       Date:  2021-01       Impact factor: 6.914

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.